encapdrugdelivery.com Report : Visit Site

Technical data of the encapdrugdelivery.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host encapdrugdelivery.com. Currently, hosted in United States and its service provider is E.I. du Pont de Nemours and Co. Inc. .

the related websites

ikea.com maplin.co.uk generationterrorists.com bbc.co.uk techradar.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

biopharmaceuticals our capabilities by service product design clinical trial materials & services finished dosage forms capsules by challenge bioavailability enhancement targeted delivery inhalation formulation lipid & liquid based formulations taste & odor masking browse all by technology spray dried dispersion inhalation technology lipid multiparticulate technology liquid filled hard capsule technology micronization browse all by product development site bend, oregon, usa edinburgh, scotland ploërmel, france tampa, florida, usa browse all how we work our process project lifecycle support quality & regulatory quality & responsibility regulatory assistance facilities & locations meet the team at our bend, oregon, usa facility browse all contact us locations & facilities consumer health & nutrition our capabilities by market opportunity herbs & botanicals digestive health clean label healthy aging vegetarian products browse all by product type empty vegetarian capsules filled hard capsules functional capsules taste & odor masking ingredients & intermediates browse all trending now lonza completes acquisition of capsugel to create leading integrated solutions provider to the global pharma and consumer healthcare industries cultivate your probiotic performance: market trends and innovative solutions vegetarian products healthy aging working with capsugel custom solutions market & consumer insights formulation support manufacturing & technical services building your brand encapsulation equipment quality & regulatory capsule quality product certifications quality & responsibility regulatory assistance facilities & locations meet the team at our bend, oregon, usa facility browse all contact us locations & facilities about us overview about capsugel now a lonza company earning trust quality & responsibility regulatory assistance careers news & events news events & webinars in the news media inquiries contact us locations & facilities knowledge center english chinese japanese portuguese russian contact us type to search edinburgh, scotland capsugel’s facilities in edinburgh, scotland, are home to its center of excellence for liquid-filled hard-capsule (lfhc) technology. this enabling technology platform serves a global market with integrated product design, development, and manufacturing of pharmaceutical products. the edinburgh facility is the largest dedicated pharmaceutical liquid and semisolid production site for lfhc technology in the world and capsugel has an extensive record there designing and optimizing lipid, semi-solid and liquid formulations, as well as advancing compounds from feasibility through the clinic to commercialization. encap drug delivery units 4,5 & 6 oakbank park way livingston west lothian united kingdom eh53 0th telephone: +44 (0)1506 448080 fax: +44 (0)1506 448081 technology expertise capsugel is a global contract manufacturing and development organization and its edinburgh facility is the world's number one site for liquid and semisolid capsule products. at edinburgh, capsugel offers integrated onsite expertise in all aspects of the product development and manufacture of pharmaceuticals for oral drug delivery. the site’s specialty as a center of excellence for liquid-filled hard capsule (lfhc) technology, offers clients an advanced dosage-form solution for liquid, semisolid, paste, and multiparticulate applications, overcoming the formulation challenges associated with other types of liquid-filled capsules. in addition to our product-design and manufacturing experience with lfhc and other drug-delivery systems, edinburgh scientists offer a variety of capabilities to clients dealing with problematic compounds. center of excellence for liquid-filled hard capsule (lfhc) technology the capsugel site in edinburgh has more than 25 years of experience in the development and optimization of lfhc technology, making it the world leader and expert in this flexible and elegant dosage form. lfhc technology has a proven record for addressing complex formulation challenges, particularly since the capsules are leak proof and protect the active pharmaceutical ingredient (api) from moisture, oxygen, and light. the capsules can be used with an array of pharmaceutically approved lipid and non-lipid excipients, offering unprecedented formulation flexibility. because of these characteristics, lfhc dosage forms offer an ideal way to improve or reposition existing formulations. liquid-filled hard-capsule technology liquid-filled hard-capsule (lfhc) technology provides an advanced dosage form offered in both gelatin and hydroxypropyl methyl cellulose (hpmc) for liquid, semisolid, paste and multiparticulate applications. this unique, flexible and elegant dosage form has a proven track record for addressing complex formulation challenges. view technology liquid-filled hard capsules capsugel's two-piece liquid-filled hard capsules provide an advanced dosage form specifically designed for secure containment of liquids and semisolids. view product drug-delivery technologies capsugel’s edinburgh staff has extensive expertise in all aspects of oral drug delivery and provides clients with simple, scalable formulations designed for a successful clinical outcome. technological solutions are available for immediate- and controlled-release formulations; and combination products. particular areas of expertise include the following poorly soluble drugs which require bioavailability enhancement (lipid formulations including self-emulsifying drug-delivery systems [sedds] and self-microemulsifying drug-delivery system [smedds]); hygroscopic and oxidation sensitive compounds; highly potent and cytotoxic drugs ; immediate-, controlled- and sustained-release formulations; compounds requiring delivery to specific regions of the gi tract (e.g., small intestine or colon), such as small molecules, proteins and peptides; compounds with low melting points; and compounds with sensitivity to air, moisture, light, or other active ingredients. colonic delivery technologies capsugel has successfully used a variety of formulation strategies, including multiparticulate and capsule-coating technologies, to achieve colonic drug delivery. view technology lipid multiparticulate technology combining the functionality of lipids and flexibility of multiparticulates, capsugel’s lipid multiparticulate technology provides an attractive formulation option for specialized applications, such as pediatrics and geriatric patients. view technology pharmaceutical development services as the world’s largest company dedicated to liquid and semi-solid encapsulation, capsugel understands product development. the company offers a full range of preformulation and formulation development services for new substances or upgrades of existing products. in edinburgh, product design expertise includes lipid/solvent/cosolvent formulations, liquid/semi-solid products, targeted colonic-delivery products using lfhc and specialized coatings, dual delivery products with specialized capsule-in-capsule technology, and abuse-deterrent formulations. formulation expertise and product development capsugel's experienced team at edinburgh has helped hundreds of clients advance their molecules quickly and cost effectively to clinical evaluation, while minimizing the risk of formulation failure. we provide a full range of pharmaceutical development services from preformulation to prototype formulations for clinical trials, tailoring these to the needs of the client—whether they want a rapid first-in-human development program or a formulation optimized with commercial manufacturing in mind. our technologies include: capsule-in-capsule for delivery of the same or different apis, formulations for targeted delivery to the colon, and abuse-deterrent formulations to deter extraction of controlled drugs or pain medicines. capsugel technologies are applicable to all compounds and especially those which are poorly soluble, have poor bioavailability or are oxygen- or moisture-sensitive; small molecules and biomolecules (e.g., proteins and peptides); controlled drugs; and compounds which are highly potent (e.g., cytotoxics, cytostatics). our technologies offer the following advantages formulation is fast for first-in-human, providing an excellent development tool to get to decision making points faster; less api is required for formulation development compared to tablet and iv formulation; ease of scale-up enables faster development during all phases of clinical development; enables targeted delivery of drugs; and appropriate for lifecycle management and patent life extension. manufacturing services capsugel supports clients for all their clinical trial manufacturing needs (phase i to iv) and with full commercial-scale manufacturing. this includes high-containment manufacturing for highly potent and cytotoxic products. our state-of-the-art facility in the united kingdom is the largest in the world for the manufacture of liquid and semi-solid filled capsule pharmaceutical products, offering clients unrivalled capacity and flexibility. this facility is approved by the fda and licensed by the mhra. the staff at edinburgh has built up an unrivalled level of experience and track record in this area, offering more than 25 years of experience of capsule manufacturing (filling, banding and coating of capsules); a focus on regulated pharmaceutical products (e.g., rather than nutraceuticals); experience in scale up and validation required for commercial manufacture; experience manufacturing more than 20 commercial products; manufacturing capacity to transfer in existing commercial products, including soft-gel switches and capsules sealed with alternative technologies (lems); flexibility in terms of manufacturing batch sizes and experience with commercial volumes from less than 1 m to 100 m; and expanding capacity and a commitment to invest in our facility and equipment design, development or manufacturing challenge? contact us a model-based methodology for spray-drying process development april 16, 2018 view amorphous solid dispersion formulations using the spray dry process - performance, stability and manufacture march 27, 2018 view hot-melt extrusion of amorphous solid dispersion for bioavailability enhancement march 27, 2018 view years of experience in capsule manufacturing 25 privacy and cookies notice please note that lonza has updated its privacy policy . by visiting our website or using services provided by lonza, you are accepting the practices described in the privacy policy. we also use cookies on our websites. cookies allow us to give you the best browsing experience and help us to understand how you use our site. you can disable cookies but parts of our website may not work. please read our updated cookies policy for information about which cookies we use and the information we collect. by continuing to use this website, you agree that we may store and access cookies on your device. by clicking "i agree", you confirm that you are above the age of 16, that you have read and understood the privacy policy and the cookies policy, and that you agree to the collection, use and processing of your personal information by lonza in accordance with said policies. i agree terms of services privacy policy cookie policy sitemap copyright 2018 contact us biopharmaceuticals our capabilities product design clinical trial materials & services finished dosage forms capsules how we work project lifecycle support quality assurance regulatory assistance consumer health & nutrition our capabilities market opportunities product portfolio working with capsugel formulation support manufacturing & technical services building your brand encapsulation equipment capsule quality product certifications quality and responsibility regulatory assistance about us about capsugel now a lonza company earning trust quality & responsibility regulatory assistance news events & webinars locations & facilities careers contact us knowledge center register for an account already a member? login terms of services privacy policy cookie policy sitemap copyright 2018 contact us

URL analysis for encapdrugdelivery.com

https://www.capsugel.com/knowledge-center/a-model-based-methodology-for-spray-drying-process-development
https://www.capsugel.com/locations/livingston-scotland/biopharmaceutical-technologies/micronization
https://www.capsugel.com/biopharmaceutical-technologies/colonic-delivery-technologies
https://www.capsugel.com/locations/livingston-scotland/biopharmaceutical-technologies/lipid-multiparticulate-technology
https://www.capsugel.com/locations/livingston-scotland/media-inquiries
https://www.capsugel.com/locations/livingston-scotland/manufacturing-technical-services
https://www.capsugel.com/locations/livingston-scotland/biopharmaceutical-technologies/liquid-filled-hard-capsule-technology
https://www.capsugel.com/locations/livingston-scotland/knowledge-center
https://www.capsugel.com/knowledge-center/hot-melt-extrusion-of-amorphous-solid-dispersion-for-bioavailability-enhancement
https://www.capsugel.com/locations/livingston-scotland/product-suites/herbs-botanicals
https://www.capsugel.com/locations/livingston-scotland/product-suites/vegetarian-products
https://www.capsugel.com/locations/livingston-scotland/knowledge-center/biopharmaceuticals
https://www.capsugel.com/locations/livingston-scotland/product-suites/functional-capsules
https://www.capsugel.com/locations/livingston-scotland/contact?d=eyj0axrszsi6ikrlc2lnbiwgzgv2zwxvcg1lbnqgb3igbwfudwzhy3r1cmluzybjagfsbgvuz2u/iiwicmvmzxjyaw5nugfnzvvybci6imh0dhbzolwvxc93d3cuy2fwc3vnzwwuy29txc9sb2nhdglvbnncl2xpdmluz3n0b24tc2nvdgxhbmqilcjyzwzlcnjpbmdvdg1qyxjhbxmionsidxrtu291cmnlijpudwxslcj1dg1nzwrpdw0iom51bgwsinv0bunhbxbhawduijpudwxsfswicmvmzxjyaw5nugfnzuludgvyzxn0cyi6wyjmaxf1awqgrmlsbgvkiehhcmqgq2fwc3vszxmixx0=
https://www.capsugel.com/locations/livingston-scotland/product-suites/healthy-aging

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: encapdrugdelivery.com
Registry Domain ID: 89157146_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.markmonitor.com
Registrar URL: http://www.markmonitor.com
Updated Date: 2017-07-08T02:18:11-0700
Creation Date: 2002-08-08T05:52:55-0700
Registrar Registration Expiration Date: 2019-08-08T00:00:00-0700
Registrar: MarkMonitor, Inc.
Registrar IANA ID: 292
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.2083895740
Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited)
Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited)
Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited)
Registry Registrant ID:
Registrant Name: Domain Administrator
Registrant Organization: Capsugel Belgium NV
Registrant Street: Rijksweg 11,
Registrant City: Bornem
Registrant State/Province:
Registrant Postal Code: B-2880
Registrant Country: BE
Registrant Phone: +32.38900511
Registrant Phone Ext:
Registrant Fax: +32.38892622
Registrant Fax Ext:
Registrant Email: [email protected]
Registry Admin ID:
Admin Name: Domain Administrator
Admin Organization: Capsugel Belgium NV
Admin Street: Rijksweg 11,
Admin City: Bornem
Admin State/Province:
Admin Postal Code: B-2880
Admin Country: BE
Admin Phone: +32.38900511
Admin Phone Ext:
Admin Fax: +32.38892622
Admin Fax Ext:
Admin Email: [email protected]
Registry Tech ID:
Tech Name: Domain Administrator
Tech Organization: Capsugel Belgium NV
Tech Street: Rijksweg 11,
Tech City: Bornem
Tech State/Province:
Tech Postal Code: B-2880
Tech Country: BE
Tech Phone: +32.38900511
Tech Phone Ext:
Tech Fax: +32.38892622
Tech Fax Ext:
Tech Email: [email protected]
Name Server: ns3.markmonitor.com
Name Server: ns6.markmonitor.com
Name Server: ns4.markmonitor.com
Name Server: ns2.markmonitor.com
Name Server: ns7.markmonitor.com
Name Server: ns5.markmonitor.com
Name Server: ns1.markmonitor.com
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2017-07-15T08:29:29-0700 <<<

The Data in MarkMonitor.com's WHOIS database is provided by MarkMonitor.com for
information purposes, and to assist persons in obtaining information about or
related to a domain name registration record. MarkMonitor.com does not guarantee
its accuracy. By submitting a WHOIS query, you agree that you will use this Data
only for lawful purposes and that, under no circumstances will you use this Data to:
(1) allow, enable, or otherwise support the transmission of mass unsolicited,
commercial advertising or solicitations via e-mail (spam); or
(2) enable high volume, automated, electronic processes that apply to
MarkMonitor.com (or its systems).
MarkMonitor.com reserves the right to modify these terms at any time.
By submitting this query, you agree to abide by this policy.

MarkMonitor is the Global Leader in Online Brand Protection.

MarkMonitor Domain Management(TM)
MarkMonitor Brand Protection(TM)
MarkMonitor AntiPiracy(TM)
MarkMonitor AntiFraud(TM)
Professional and Managed Services

Visit MarkMonitor at http://www.markmonitor.com
Contact us at +1.8007459229
In Europe, at +44.02032062220

For more information on Whois status codes, please visit
https://www.icann.org/resources/pages/epp-status-codes-2014-06-16-en


  REGISTRAR MARKMONITOR INC.

  REFERRER http://www.markmonitor.com

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =encapdrugdelivery.com

  PORT 43

  SERVER whois.markmonitor.com

  ARGS encapdrugdelivery.com

  PORT 43

  TYPE domain

DOMAIN

  NAME encapdrugdelivery.com

NSERVER

  NS1.MARKMONITOR.COM 64.124.69.50

  NS2.MARKMONITOR.COM 162.88.60.13

  NS3.MARKMONITOR.COM 162.88.61.15

  NS4.MARKMONITOR.COM 162.88.60.15

  NS5.MARKMONITOR.COM 162.88.61.17

  NS6.MARKMONITOR.COM 162.88.60.17

  NS7.MARKMONITOR.COM 162.88.61.19

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

  CHANGED 2017-07-08

  CREATED 2002-08-08

  EXPIRES 2019-08-08

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .